BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29956684)

  • 1. The novel long noncoding RNA LOC283070 is involved in the transition of LNCaP cells into androgen-independent cells via its interaction with PHB2.
    Zhang Y; Wang LN; Lin YN; Xing YX; Shi Y; Zhao J; Chen WW; Han B
    Asian J Androl; 2018; 20(5):511-517. PubMed ID: 29956684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA LOC283070 mediates the transition of LNCaP cells into androgen-independent cells possibly via CAMK1D.
    Wang L; Lin Y; Meng H; Liu C; Xue J; Zhang Q; Li C; Zhang P; Cui F; Chen W; Jiang A
    Am J Transl Res; 2016; 8(12):5219-5234. PubMed ID: 28077997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.
    Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y
    Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway.
    Li X; Li T; Chen D; Zhang P; Song Y; Zhu H; Xiao Y; Xing Y
    Oncol Rep; 2016 Jan; 35(1):584-92. PubMed ID: 26534764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.
    Chen M; Feuerstein MA; Levina E; Baghel PS; Carkner RD; Tanner MJ; Shtutman M; Vacherot F; Terry S; de la Taille A; Buttyan R
    Mol Cancer; 2010 Apr; 9():89. PubMed ID: 20420697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription.
    Bebermeier JH; Brooks JD; DePrimo SE; Werner R; Deppe U; Demeter J; Hiort O; Holterhus PM
    J Mol Med (Berl); 2006 Nov; 84(11):919-31. PubMed ID: 16932916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression.
    Zhang Y; Pitchiaya S; Cieślik M; Niknafs YS; Tien JC; Hosono Y; Iyer MK; Yazdani S; Subramaniam S; Shukla SK; Jiang X; Wang L; Liu TY; Uhl M; Gawronski AR; Qiao Y; Xiao L; Dhanasekaran SM; Juckette KM; Kunju LP; Cao X; Patel U; Batish M; Shukla GC; Paulsen MT; Ljungman M; Jiang H; Mehra R; Backofen R; Sahinalp CS; Freier SM; Watt AT; Guo S; Wei JT; Feng FY; Malik R; Chinnaiyan AM
    Nat Genet; 2018 Jun; 50(6):814-824. PubMed ID: 29808028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase.
    Yu P; Duan X; Cheng Y; Liu C; Chen Y; Liu W; Yin B; Wang X; Tao Z
    Int J Mol Med; 2017 Nov; 40(5):1426-1434. PubMed ID: 28901378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence.
    Wang L; Han S; Jin G; Zhou X; Li M; Ying X; Wang L; Wu H; Zhu Q
    Int J Oncol; 2014 Jun; 44(6):2041-9. PubMed ID: 24691949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
    Dulinska-Litewka J; McCubrey JA; Laidler P
    Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and regulation of androgen receptor in the androgen-independent conversion of prostate cancer cells].
    Wang HF; Liu WJ; Jin J; Zhou LQ; Liang LL; Wang Y; Guo YL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):490-5. PubMed ID: 21844951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
    Wang Y; Liu G; Tong D; Parmar H; Hasenmayer D; Yuan W; Zhang D; Jiang J
    Prostate; 2015 Aug; 75(11):1187-96. PubMed ID: 25894097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA GAS5 participates in the regulation of dexamethasone on androgen receptor -negative and -positive prostate cancer cell proliferation.
    Hu J; Deng J; Cao R; Xiong S; Guo J
    Mol Cell Probes; 2020 Oct; 53():101607. PubMed ID: 32470500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel lncRNA
    Lingadahalli S; Jadhao S; Sung YY; Chen M; Hu L; Chen X; Cheung E
    Mol Cancer Res; 2018 Dec; 16(12):1865-1878. PubMed ID: 30115758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer.
    Dong Z; Liu Y; Lu S; Wang A; Lee K; Wang LH; Revelo M; Lu S
    Mol Endocrinol; 2006 Oct; 20(10):2315-25. PubMed ID: 16762975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krüppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer.
    He HJ; Gu XF; Xu WH; Yang DJ; Wang XM; Su Y
    Acta Pharmacol Sin; 2013 Feb; 34(2):282-8. PubMed ID: 23023312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.